Author: starbpo

In Season 2, Noah (played by Adam Brody) and Joanne (played by Kristen Bell) become serious in Netflix’s popular romantic comedy “Nobody Wants This.” Sports fans will be under pressure to add one or two more services in October, during an otherwise slow month for streaming. This is because, in addition to certain games that are only available on ESPN, Peacock and Amazon Prime Video will now broadcast NBA games nationally each week. Fans are increasingly left wondering where to watch their favorite team’s games on any given night and whether it’s worth paying extra each month to catch every…

Although lumber costs are lower now than they were a few years ago, the economy is still struggling with inflation. The data: Although a crucial indicator of inflation increased somewhat in August, it was not high enough to indicate that much larger increases linked to U.S. tariffs were imminent. Top Fed officials are expected to be reassured by the most recent price report that inflation is still mostly under control, even if it has been rising since the spring due in part to much increased U.S. tariffs. The Bureau of Economic Analysis said on Friday that the PCE index, the…

The Fed’s interest-rate committee will not include Richmond Fed President Tom Barkin until 2027. The U.S. economic picture appears to be a mystery. The latest set of data revealed robust consumer expenditure and steady economic growth. Economists are concerned, however, because the labor market has obviously slowed. These contradictory data indicators can indicate that the economy’s future course appears precarious. In a note to clients, Apollo chief economist Torsten Slok stated, “The economy cannot be on the verge of a recession with a weaker labor market over the same period.” The U.S. economy is now expected to grow at a…

Late Thursday, U.S. President Donald Trump unveiled a new tariff plan for pharmaceutical companies. Here, he participates in a July 2020 event about drug pricing during his first term as president. Friday saw a majority increase in pharmaceutical equities as investors seemed to ignore or even applaud President Donald Trump’s introduction of a new tariff plan for pharmaceutical companies. Trump stated in a social media post late Thursday that his government will begin levying a 100% duty on any branded or copyrighted pharmaceutical product on Wednesday, unless the producer is building a U.S. facility or has one already in place.…

The sculpture “Fearless Girl” at the New York Stock Exchange. As investors continue to ignore last week’s little decline from record highs, futures indicate that equities are off to a strong start in the penultimate session of the quarter. Notwithstanding a number of possible market catalysts over the coming days, most notably news about the U.S. jobs sector, the Cboe Volatility index VIX is below 16, indicating that traders are optimistic. However, if another market obstacle—a complete shutdown of the U.S. government—occurs in the middle of the week, it’s likely that the official nonfarm payrolls number won’t be released on…

Before the end of August, Corporate America will have repurchased almost $1 trillion worth of its own stock at a historic pace. The overall effect of President Trump’s major measures will be to further exacerbate the trend, even if none of his policies specifically encourage share buybacks. This is in line with the forecasts of Gavekal Research, which says that more stock repurchases will occur in the future, adding to the current bull market’s tailwind. Why is this the case? The first and most compelling factor is an indirect result of the One Big Beautiful Bill Act, which was passed…

Months after a successful cancer medication study, Merus consented to be purchased at a 41% premium. The Utrecht, Netherlands-based Merus (MRUS) is being acquired by Danish-Dutch biotech Genmab (GMAB) (DK:GMAB) for $8 billion, or $97 per share. Merus shares increased 38% in premarket U.S. trading, while Genmab shares fell 3% in Copenhagen trade. A late-stage asset with two breakthrough treatment designations, petosemtamab, would be added to Genmab’s portfolio as a result of the purchase, the company said. Patients with head and neck cancer may find that petosemtamab is a life-changing treatment. “We are certain that we will be able to…

Investors could have a spectacular end to September. Long-term stock prices could benefit from this week’s positive economic news. However, any economic news could be helpful. In September, U.S. stocks have done well, even though it’s usually a difficult month for markets. However, it now appears that a possible government shutdown will occur in the middle of the week, just as investors are wrapping up the month and quarter. Crucially, a shutdown might prevent the release of the crucial jobs report in September. “This could come at a really unfortunate time because we are supposed to get the jobs report…

Consumers purchase the newest models of the company’s well-known phones and other products at the Apple Store on Fifth Avenue in New York. The U.S. economy has enough problems to convince the Fed to lower interest rates last week, but the news isn’t all that grim. Numerous recent studies also demonstrate that consumer expenditure is still sufficient to support an expanding economy and prevent a recession. Furthermore, although inflation has increased, it hasn’t done so at the rate that experts had anticipated when the trade battles broke out earlier this year. First, let’s talk about personal spending, which is the…

This week, an increasing number of hedge fund founders and strategists appeared pessimistic about the AI trade. Based on market activity, it may not seem like much, but this week on Wall Street, there were some skepticisms over the sustainability of the artificial intelligence industry. Reports on possible dangers to the AI narrative were released by a number of well-known analysts. Concerns regarding circular financing in AI and the source of funding for these new data-center commitments were rekindled by recent agreements between Oracle Corp. (ORCL) and OpenAI, as well as OpenAI and Nvidia Corp. (NVDA). For the first time,…